+ All Categories
Home > Documents > Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8%...

Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8%...

Date post: 14-Aug-2020
Category:
Upload: others
View: 3 times
Download: 0 times
Share this document with a friend
20
Earnings Presentation Q2’14 August 13, 2014
Transcript
Page 1: Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8% 1,749 12.0% Pharmacies 512 16.6% 995 16.6%

Earnings

Presentation

Q2’14

August 13, 2014

Page 2: Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8% 1,749 12.0% Pharmacies 512 16.6% 995 16.6%

This material was prepared solely for informational purposes and is not to be construed as a solicitation or an offer to buy or sell any securities.

This presentation may include forward-looking statements or statements about events or circumstances which have not yet occurred. We have based these forward-looking statements largely on our current

beliefs and expectations about future events and financial trends affecting our businesses and our future financial performance. These forward-looking statements are subject to risk, uncertainties and

assumptions, including, among other things, general economic, political and business conditions, both in Peru and in Latin America as a whole. The words “believes”, “may”, “will”, “estimates”, “continues”,

“anticipates”, “intends”, “expects”, and similar words are intended to identify forward-looking statements. We undertake no obligations to update or revise any forward-looking statements because of new

information, future events or other factors.

In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this presentation might not occur. Therefore, our actual results could differ substantially from those

anticipated in our forward-looking statements.

No representation or warranty, either express or implied, is provided in relation to the accuracy, completeness or reliability of the information contained herein. It should not be regarded by recipients as a

substitute for the exercise of their own judgment. We and our affiliates, agents, directors, employees and advisors accept no liability whatsoever for any loss or damage of any kind arising out of the use of all or

any part of this material.

This material does not give and should not be treated as giving investment advice. You should consult with your own legal, regulatory, tax, business, investment, financial and accounting advisers to the extent

that you deem it necessary, and make your own investment, hedging and trading decision based upon your own judgment and advice from such advisers as you deem necessary and not upon any information

in this material.

2

Page 3: Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8% 1,749 12.0% Pharmacies 512 16.6% 995 16.6%

AGENDA

Q2’14 Financial Results by Segment

Q2’14 Highlights 01

02

03 Recent Event: Senior Notes Issuance

Page 4: Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8% 1,749 12.0% Pharmacies 512 16.6% 995 16.6%

01

Q2’14 Highlights

Page 5: Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8% 1,749 12.0% Pharmacies 512 16.6% 995 16.6%

Opened Real Plaza Salaverry shopping mall on

time and budget (+ 72k sqm of GLA)

Opened 2 supermarkets in Lima (San Isidro and

Salaverry), expanded one supermarket, and

closed 2 legacy format Economax stores

(+8,250 new sqm of sales area, +4,782 sqm of

sales area net of closings)

Remodeled and improved layouts on 3

supermarkets

Opened 23 pharmacies (3 stores in Lima / 20 in

provinces); successfully launched marketing

campaigns of new high margin products in

Pharmacies segment

Accelerated same-store-sales growth in both

Supermarkets and Pharmacies segments

Q2’14 Highlights

5

01

Page 6: Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8% 1,749 12.0% Pharmacies 512 16.6% 995 16.6%

-54

56

-40

90

Q2'13 Q2'14 YTD'13 YTD'14

101

131

205

248

Q2'13 Q2'14 YTD'13 YTD'14

1,258 1,459

2,491

2,865

Q2'13 Q2'14 YTD'13 YTD'14

Margin -1.6% 3.1% -4.3% 3.9%

Formatting

Font: Arial

Bullets:

Level 1

Level 2

Color code:

2013 Consolidated Results Million Soles (S/. mm)

Q2’14 Highlights Revenues

Margin 8.2% 8.7% 8.0% 9.0%

Q2’14 Consolidated Results Million Soles (S/. mm)

01

Adj. EBITDA Net Income

• 15.9% growth in Revenues

• 2 supermarkets opened

• 23 pharmacies added to the network

• +74k sqm of additional GLA of shopping malls (opening of

Real Plaza Salaverry and expansions)

• +5.2% SSS in Supermarkets, +10.8% SSS in Pharmacies

• 29.2% growth in Adj. EBITDA

• Net Income for Q2’14 was S/.56 million; Excluding Forex and

mark-to-market, Net Income increased 215.7%

6

Page 7: Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8% 1,749 12.0% Pharmacies 512 16.6% 995 16.6%

Q2’14 Financial

Results by Segment

02

Page 8: Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8% 1,749 12.0% Pharmacies 512 16.6% 995 16.6%

Var% Var%

Q2'13 YTD'13

Supermarkets 880 12.8% 1,749 12.0%

Pharmacies 512 16.6% 995 16.6%

Shopping Centers 79 60.1% 145 50.2%

Eliminations -13 16.6% -25 20.7%

Total revenues 1,459 15.9% 2,865 15.0%

Q2'14 YTD'14

Supermarkets

Pharmacies

Shopping Malls

• +60.1% vs. Q2’13; +50.2% vs. YTD’13

• Opening of Real Plaza Salaverry and expansion of one shopping mall

(74k sqm) in Q2’14, 180k sqm of additional GLA since Q2’13 (+56.5%),

total 499k sqm (558k sqm including related parties’)

• +16.6% vs. Q2’13; +16.6% vs. YTD’13

• Q2’14 SSS: +10.8%; YTD’14 SSS: +10.1%

• 23 pharmacies added to the network in Q2’14, 118 pharmacies since

Q2’13 (+18.6%), total 754 stores

• +12.8% vs. Q2’13; +12.0% vs. YTD’13

• Q2’14 SSS: +5.2%; YTD’14 SSS: +5.0%

• 4,782 sqm of additional sales area in Q2’14, 10 new stores since Q2’13

(+11.7%, 26,616 sqm), total 98 stores (253,391 sqm)

2013 Consolidated Results Million Soles (S/. mm)

Revenues Growth of 15.9% vs Q2’13 Million Soles (S/. mm)

02

Pharmacies

34.2%

Shopping Centers

4.6%

LTM Q2’14 Revenues Breakdown

Revenues

Supermarkets

61.2%

8

Page 9: Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8% 1,749 12.0% Pharmacies 512 16.6% 995 16.6%

227 227 228

249 249

253

Q1'13 Q2'13 Q3'13 Q4'13 Q1'14 Q2'14

-0.7%

-2.1%

2.1%2.4%

4.8%5.2%

Q1'13 Q2'13 Q3'13 Q4'13 Q1'14 Q2'14

297 319 336

399 425

499

Q1'13 Q2'13 Q3'13 Q4'13 Q1'14 Q2'14

610

636

675

725 731

754

Q1'13 Q2'13 Q3'13 Q4'13 Q1'14 Q2'14

Quarterly Openings and SSS by Segment 02

Shopping Malls

GLA (‘000 sqm)

N° Stores 88 88 90 98

Pharmacies

N° Stores

Supermarkets

Openings Same Store Sales

98 98

-1.1%

0.4%

4.0%

6.9%

9.3%

10.8%

Q1'13 Q2'13 Q3'13 Q4'13 Q1'14 Q2'14

Pharmacies

9

Supermarkets

Sales Area (‘000 sqm)

Page 10: Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8% 1,749 12.0% Pharmacies 512 16.6% 995 16.6%

• +76.5% vs. Q2’13; +56.1% vs. YTD’13

• EBITDA Mg. 53.8% vs. 48.8% in Q2’13; 54.3% YTD’14 vs. 52.3% YTD’13

• Higher margin driven by an increase in revenues and dilution of fixed

costs despite higher pre-operational expenses related to the opening of

Real Plaza Salaverry

• +3.5% vs. Q2’13; +13.1% vs. YTD’13

• EBITDA Mg. 5.0% vs. 5.4% in Q2’13; 5.6% YTD’14 in line with YTD’13

• +3.5% vs Q2’13, that includes S/.20 mm paid by Tarjeta Oh! as entry fee,

due to higher commercial and logistic contribution from suppliers and

store efficiencies

Var% Var%

Q2'13 YTD'13

Adj. EBITDA:

Supermarkets 44 5.0% 3.5% 98 5.6% 13.1%

Pharmacies 46 8.9% 27.0% 84 8.5% 20.1%

Shopping Centers 43 53.8% 76.5% 79 54.3% 56.1%

Eliminations and holding -1 10.9% -13 442.4%

Total Adj. EBITDA 131 9.0% 29.2% 248 8.7% 21.0%

Q2'14 %Rev YTD'14 %Rev

• +27.0% vs. Q2’13; +20.1% vs. YTD’13

• EBITDA Mg. 8.9% vs. 8.2% in Q2’13; 8.5% YTD’14 vs. 8.2% YTD’13

• Higher gross margin due to an increase in penetration of high margin

products compensated higher logistic and warehousing expenses, and

higher operating expenses due to new stores in early stage of operation

02

Adjusted EBITDA Growth of 29.2% vs Q2’13 Million Soles (S/. mm)

Supermarkets

Pharmacies

Shopping Malls

Adj. EBITDA

Shopping Centers

26.9%

Pharmacies

31.6%

LTM Q2’14 Adj. EBITDA Breakdown

Supermarkets

41.5%

10

Page 11: Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8% 1,749 12.0% Pharmacies 512 16.6% 995 16.6%

94 87

100

128

104 101 111

158

118

131

Q1 Q2 Q3 Q4

2012 2013 2014

17

14

24 24 27

24 26

37 36

43

Q1 Q2 Q3 Q4

2012 2013 2014

33 32

37 34 34

36

43 41

39

46

Q1 Q2 Q3 Q4

2012 2013 2014

45 42 38

72

45 42 42

81

55

44

Q1 Q2 Q3 Q4

2012 2013 2014

02

Adjusted EBITDA Evolution Million Soles (S/. mm)

InRetail Consolidated Supermarkets

Pharmacies Shopping Malls

11

Page 12: Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8% 1,749 12.0% Pharmacies 512 16.6% 995 16.6%

-54

56

-40

90

Q2'13 Q2'14 YTD'13 YTD'14

13

40 41

67

Q2'13 Q2'14 YTD'13 YTD'14

Net Income excluding after-tax forex

and mark-to-market gains:

Excl. Forex and Mark-to-Market, Net Income Increased of 215.7% vs Q2’13

Consolidated Net Income of S/. 56 million in Q2’14,

compared to a loss of S/. 54 million in Q2’13. Excluding forex

and gain in fair value of investment properties, Net Income

increased 215.7% in Q2’14 due to:

Higher operating profit

Lower financial expenses and higher financial

income

Foreign exchange effects:

Exchange gain of S/. 7.1 million in Q2’14 vs. loss of

S/. 96.1 million in Q2’13

Exchange gain of S/. 1.0 million YTD’14 vs. loss of

S/. 117.5 million YTD’13

Higher increase in fair value of investment properties:

Mark-to-market gain of S/. 16.7 million in Q2’14 vs.

S/. 0.8 million in Q2’13

Mark-to-market gain of S/. 32.2 million YTD’14 vs.

S/. 2.7 million YTD’13

02

Consolidated Net Income Q2’14 vs Q2’13 Million Soles (S/. mm)

12

Net

Margin -1.6% -4.3% 3.9%

Net Income:

3.1%

Net

Margin 1.6% 1.0% 2.7% 2.3%

Page 13: Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8% 1,749 12.0% Pharmacies 512 16.6% 995 16.6%

13

02

Consolidated Capex and Financial Debt Million Soles (S/. mm)

Capex Financial Debt

5.0x

4.0x 3.6x 3.6x 3.5x

3.9x

1.3x

2.9x 3.2x 3.1x

2011 2012 2013 LTMQ1'14

LTMQ2'14

Debt / EBITDA Net Debt / EBITDA

Debt 1,561 1,668

Cash 353 1,125

Net

Debt 1,208 542

1,722

324

1,398

1,773

194

1,580

1,827

201

1,627

299

189 176

370

114

242

Q1'13 Q2'13 Q3'13 Q4'13 Q1'14 Q2'14

Total Capex 2013: S/. 1,034 mm

Page 14: Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8% 1,749 12.0% Pharmacies 512 16.6% 995 16.6%

14

02

Debt by Segments As of June 30th, 2014

73%

Debt / EBITDA: 3.5x

Net Debt / EBITDA: 3.1x

Retail Segments & Holding Co.1/ Shopping Malls Segment

1/ The retail segments and the holding company (excluding shopping malls segment) represent restricted subsidiaries for purposes of the Intercorp Retail US$ 300 MM

8.875% Senior Guaranteed Notes due 2018, which, together with the US$ 29.1 MM debt (as of June 30th, 2014) of our parent company, Intercorp Retail, comprise the

total restricted group debt.

Total Consolidated Debt: S/. 1,827 mm

Q2'14

Debt 1,111

Cash 138

Net Debt 974

EBITDA LTM Jun'14 390

Debt/EBITDA 2.9x

Net Debt/EBITDA 2.5x

Q2'14

Debt 716

Cash 63

Net Debt 653

EBITDA LTM Jun'14 143

Debt/EBITDA 5.0x

Net Debt/EBITDA 4.6x

Page 15: Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8% 1,749 12.0% Pharmacies 512 16.6% 995 16.6%

03

Recent Event:

Senior Notes Issuance

Page 16: Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8% 1,749 12.0% Pharmacies 512 16.6% 995 16.6%

03

17

InRetail Shopping Malls Recently Issued Two

Bonds

Issuer InRetail Shopping Malls

Size US$ 350 million S/.141 million

Format 144A / Reg. S Reg. S

Coupon 6.500% 7.875%

Structure

7NC4 Final: July 9th 2021; 1st Call Date: July 9tth 2018 20 year, Amortization starting in 2030;

Final: July 25th 2034

Senior Unsecured Notes

Issue Ratings Ba2 (stable) by Moody’s/ BB (stable) by Fitch

Use of Proceeds /

Impact

i. Refinance US$ 180 million of Interproperties

Holding Notes

ii. Reduce cost of finance

iii. Have a lighter amortization schedule, freeing

up cash

iv. Acquire a real estate property named Puruchuco, for

the future development of a shopping mall (expected

GLA of 110k sqm to be opened in 2016)

v. Finance expansion of other shopping malls

i. Refinance S/. 141 million of financial obligations

ii. Reduce cost of finance

iii. Have a lighter amortization schedule, freeing

up cash

Page 17: Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8% 1,749 12.0% Pharmacies 512 16.6% 995 16.6%

03

Issuance Structure

18

Real Estate

Trusts

Management

Companies

Downstream

Guarantee

Upstream

Guarantee

Upstream

Guarantee

Issuer

New Senior Notes:

• US$ 350 MM

• S/. 141 MM

Debt:

• Leasings & Other debt:

S/. 79 MM (US$ 28 MM)

Debt:

• Leasings & Other debt:

S/. 0.5 MM (US$ 0.2 MM)

Panama

Peru

Page 18: Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8% 1,749 12.0% Pharmacies 512 16.6% 995 16.6%

03

Pro Forma Debt As of June 30th, 2014

73%

InRetail Consolidated Shopping Malls Segment InRetail Consolidated Shopping Malls Segment

Current

Q2'14Adj.

Pro Forma

Q2'14

Debt 716 485 1,200

Cash 63 386 449

Net Debt 653 99 752

EBITDA LTM Jun'14 143 - 143

Debt/EBITDA 5.0x 8.4x

Net Debt/EBITDA 4.6x 5.2x

Current

Q2'14Adj.

ProForma

Q2'14

Debt 1,827 485 2,312

Cash 201 386 587

Net Debt 1,627 99 1,725

EBITDA LTM Jun'14 518 - 518

Debt/EBITDA 3.5x 4.5x

Net Debt/EBITDA 3.1x 3.3x

Covenants:

Current

Q2'14

Pro Forma

Q2'14

Total Debt / Total Assets (<60%) 27.3% 38.7%

Secured Debt / Total Assets (<30%) 27.3% 2.1%

EBITDA / Interest Expense (>1.75x) 2.3x 2.3x

Unencumb. Assets / Unsecured Debt (>150%) na 185.5%

19

Page 19: Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8% 1,749 12.0% Pharmacies 512 16.6% 995 16.6%

03

Strong growth without additional CAPEX

Real Plaza Cusco

Real Plaza Cajamarca

Real Plaza Salaverry Our Shopping Malls segment and InRetail Peru Corp.

Consolidated LTM EBITDA figures as of June 2014, do not

fully reflect the EBITDA generated in a full year by the shopping

malls recently opened and under operation:

Therefore, we expect our Net Debt/EBITDA as of December

2014 to be below our December 2013 figures:

Largest mall in the city

First and only mall in the city

Flagship mall opened in a prime location in Lima

Date Opened GLA

As of June ‘14

Occupancy

As of June ‘14

Real Plaza

Salaverry May 2014 72k 88.8% 2/

Real Plaza

Cusco December 2013 35k 96.6%

Real Plaza

Cajamarca December 2013 38k 91.7%

20

Expected Net Debt /

EBITDA 2014

InRetail Peru Corp < 2.9x

Retail Segments & Hold.Co. < 2.4x

Shopping Malls Segment < 4.6x

2/ The mall is 100% leased as of August 2014.

Page 20: Presentación de PowerPoint - InRetail Presentation.pdfVar% Var% Q2'13 YTD'13 Supermarkets 880 12.8% 1,749 12.0% Pharmacies 512 16.6% 995 16.6%

August 13, 2014

For more information please contact:

InRetail Perú Corp.

Gonzalo Rosell, Head of Corporate Finance and IRO

Phone: (511) 618-8000, option 1, ext.55424

[email protected]

www.inretail.pe


Recommended